tamiflu has been researched along with Orthomyxoviridae Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kakuta, M; Kubo, S; Tokumitsu, A; Tomozawa, T; Yamashita, M | 1 |
| Fan, Z; Han, X; Jiao, P; Shi, Y; Si, L; Wang, H; Wu, X; Xiao, S; Xu, R; Yu, F; Zhang, L; Zhang, Y; Zhou, D; Zhou, X | 1 |
| Liu, J; Meng, L; Su, Y; Xiao, S; Yang, F; Yin, Z; Yu, F; Zhong, J; Zhou, D | 1 |
3 other study(ies) available for tamiflu and Orthomyxoviridae Infections
| Article | Year |
|---|---|
Laninamivir prodrug CS-8958, a long-acting neuraminidase inhibitor, shows superior anti-influenza virus activity after a single administration.
Topics: Animals; Antiviral Agents; Disease Models, Animal; Ferrets; Humans; Influenza A Virus, H1N1 Subtype; Influenza B virus; Mice; Mice, Inbred BALB C; Neuraminidase; Orthomyxoviridae Infections; Oseltamivir; Prodrugs; Treatment Outcome; Zanamivir | 2010 |
Design, synthesis and biological evaluation of novel L-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors.
Topics: Animals; Antiviral Agents; Ascorbic Acid; Dogs; Drug Design; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Madin Darby Canine Kidney Cells; Molecular Docking Simulation; Orthomyxoviridae Infections; Pentacyclic Triterpenes; Virus Internalization | 2016 |
Design, synthesis and biological evaluation of amino acids-oleanolic acid conjugates as influenza virus inhibitors.
Topics: Amino Acids; Animals; Antiviral Agents; Dogs; Drug Design; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Madin Darby Canine Kidney Cells; Molecular Docking Simulation; Oleanolic Acid; Orthomyxoviridae Infections; Virus Internalization | 2019 |